|
ID3 Associated Study Title | Authors | Year | Disease |
|
Dysregulated bone morphogenetic protein | Morty et al. | 2007 | PAH |
signaling in monocrotaline-induced | | | |
pulmonary arterial hypertension | | | |
|
ID family protein expression and regulation | Lowery et al. | 2010 | PH |
in hypoxic pulmonary hypertension | | | |
|
BMP induces EphrinB2 expression in | Kim et al. | 2012 | HHT |
endothelial cells through an | | | |
Alk1-BMPRII/ActRII-ID1/ID3-dependent | | | |
pathway: implications for hereditary | | | |
hemorrhagic telangiectasia type II | | | |
|
Id proteins are critical downstream | Yang et al. | 2013 | PAH |
effectors of BMP signaling in human | | | |
pulmonary arterial smooth muscle cells | | | |
|
Sex affects bone morphogenetic | Mair et al. | 2015 | PAH |
protein type II receptor signaling in | | | |
pulmonary artery smooth muscle | | | |
cells | | | |
|
ID3 contributes to the acquisition of | Das et al. | 2015 | IPAH, PAH |
molecular stem cell-like signature in | | | |
microvascular endothelial cells: its | | | |
implication for understanding microvascular | | |
diseases | | | |
|
ID3, estrogenic chemicals, and the | Avecilla V. | 2017 | PAH, HHT |
pathogenesis of tumor-like proliferative | | | |
vascular lesions | | | |
|
The role of ID3 and PCB153 in the | Doke MA. | 2018 | PAH |
hyperproliferation and dysregulation of | | | |
lung endothelial cells | | | |
|